rgbp Archives

Regen BioPharma Inc (OTCMKTS: RGBP) Breaking Out as Biotech Files Patent on Dendritic Cell Technologies to Augment Efficacy of Survivin mRNA Cancer Immunotherapeutic Vaccine

Regen BioPharma Inc (OTCMKTS: RGBP) is making a powerful reversal rocketing back into penny land on Friday up 46% on $1.6 million in dollar volume. RGBP...

BioPharma1 year ago

Regen BioPharma Inc (OTCMKTS: RGBP) Under Accumulation as Biotech Sleeper Makes Major Reversal Northbound (A look at Intellectual Property / mRNA Vaccine)

Regen BioPharma Inc (OTCMKTS: RGBP) is on the rise in recent trading since reversing off $0.0034 lows last week. RGBP has seen significant decline in recent...

Featured1 year ago

Regen BioPharma Inc (OTCMKTS: RGBP) Major Reversal Brewing as Biotech Looks to Commercialize its Modified mRNA anti-cancer Vaccine & Accelerate Clinical Development of its NR2F6 Therapies

Regen BioPharma Inc (OTCMKTS: RGBP) has been steadily dropping since topping out at $0.0819 in September of last year. Now it looks like its oversold and...

BioPharma2 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Northbound as Biotech Grows Valuable Patent Portfolio & Grants 2 Licenses to Oncology Pharma for $1.9 Million

Regen BioPharma Inc (OTCMKTS: RGBP) has been moving steadily northbound in recent trading as speculators move back into the stock and bid it higher. On Friday...

BioPharma2 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Heats Up as Biotech Up Lists & Signs LOI to Acquire Canary Oncoceutics, Inc

Regen BioPharma Inc (OTCMKTS: RGBP) is getting noticed by some heavy hitters after the Company reported earlier this week in its first press release since going...

Emerging Markets2 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Mega Runner as Biotech Moves Towards “Pink Current” & Cancer Vaccine Patent Approved

Regen BioPharma Inc (OTCMKTS: RGBP) is making a powerful run up the charts after the Company’s Cancer Vaccine Patent was approved August 17th 2021 Exclusively for...

Micro Cap Daily

Regen BioPharma Inc (OTCMKTS: RGBP) Breaking Out as Biotech Files Patent on Dendritic Cell Technologies to Augment Efficacy of Survivin mRNA Cancer Immunotherapeutic Vaccine

Regen BioPharma Inc (OTCMKTS: RGBP) Under Accumulation as Biotech Sleeper Makes Major Reversal Northbound (A look at Intellectual Property / mRNA Vaccine)

Regen BioPharma Inc (OTCMKTS: RGBP) Major Reversal Brewing as Biotech Looks to Commercialize its Modified mRNA anti-cancer Vaccine & Accelerate Clinical Development of its NR2F6 Therapies

Regen BioPharma Inc (OTCMKTS: RGBP) Northbound as Biotech Grows Valuable Patent Portfolio & Grants 2 Licenses to Oncology Pharma for $1.9 Million

Regen BioPharma Inc (OTCMKTS: RGBP) Heats Up as Biotech Up Lists & Signs LOI to Acquire Canary Oncoceutics, Inc

Regen BioPharma Inc (OTCMKTS: RGBP) Mega Runner as Biotech Moves Towards “Pink Current” & Cancer Vaccine Patent Approved

MSP Recovery (NASDAQ: LIFW) in the Spotlight: Legal Battles, Luxe Living, and Stock Surge

Solowin Holdings (NASDAQ: SWIN) 95% Stock Rally: Analyzing the Market Hype and IPO Impact”

Advancing Medical Frontiers: Elutia Inc.’s(NASDAQ: ELUT) Strategic Vision in a $600 Million Market

FingerMotion, Inc. (NASDAQ: FNGR): A Closer Look at its 500% Surge

Navigating the Green Wave: US Cannabis ETF (NYSE: MSOS) A Closer Look at Cannabis Stock Resurgence

First Wave BioPharma’s (NASDAQ: FWBI) Exclusive License: Repurposing Capeserod for GIT Disorder Solutions

ZyVersa Therapeutics’ (NASDAQ: ZVSA) Breakthrough: A Super Tool for Tackling Inflammation in ALS and Beyond

Creative Medical Technology NASDAQ: CELZ) Major Breakthrough: Allogeneic Cell Line Paves the Way for Diabetes Treatment

Aurora Cannabis (NASDAQ: ACB) Focuses on Debt Reduction and Positive Cash Flow Amidst Flourishing Cannabis Industry

Lucy Scientific Discovery’s (NASDAQ: LSDI) Game-Changing Move: A Closer Look at the High Times Acquisition

Axcella Therapeutics’ (NASDAQ: AXLA) Patent Triumph: A Milestone for Global IP Position

NeuBase Therapeutics (NASDAQ: NBSE) Stake Acquisition: Symetryx Urges Board to Consider $1 per Share Dividend

WM Technology’s (NASDAQ: MAPS) Stock Surges 91% in Mysterious Rally: What’s Behind the Boom?

Cannabis Industry Surges: Flora Growth Corp. (NASDAQ: FLGC) Leads the Way with 77% Intraday Jump

Virios Therapeutics (NASDAQ: VIRI) Advances Promising Antiviral Therapies for Chronic Diseases: Latest Momentum and Pipeline Developments

Analyzing the Phenomenal Surge: iCoreConnect’s (OTCQB: ICCT) Explosive Growth After Merger

Sunlands Technology’s (NYSE: STG) Remarkable Turnaround: Q2 2023 Sees Net Income Soar and Robust Growth

Nikola’s Road to Redemption: From Sky-High Debut to Recent Resurgence

Genius Group (NYSE: GNS) Short Squeeze: Recent Developments and What Investors Should Know

VCI Global (NASDAQ: VCIG) Joins Forces with Microsoft Azure OpenAI: A Tech Revolution Unleashed

T2 Biosystems (NASDAQ: TTOO): FDA Expectations and Speculation Around the ‘Next Memestock’

Novo Integrated Sciences (NASDAQ: NVOS) Gears Up for $57 Million RC Note Disbursement

Blue Apron Holdings (NASDAQ: APRN) Charts Path to Profitability in Q2 2023: Debt Elimination and Strategic Transaction

PhenomeX Inc. (NASDAQ: CELL) to Merge with Bruker Corporation in Strategic Acquisition

Wheels Up Experience Inc. (NYSE: UP) to Exchange Majority Stock for $500 Million Lifeline Amid Financial Turmoil

Delcath Systems (NASDAQ: DCTH) HEPZATO KIT Achieves FDA Approval: A Pivotal Step in Liver Cancer Treatment

Taysha Gene Therapies’ (NASDAQ: TSHA) Impressive Rally: A Look at the Driving Forces

Q2 2023 Financial Recap: Rigetti Computing’s (Nasdaq: RGTI) Latest Growth and Advancements

WeWork Inc.’s (NYSE: WE) Astonishing Stock Surge: An Enigma Amidst Bankruptcy Fears

Tango Therapeutics (NASDAQ: TNGX): Exploring the Trading Frenzy Behind a Remarkable 179% Gain

BIOLASE, Inc. (NASDAQ: BIOL) Takes Center Stage: Landmark Agreement with Department of Defense

Yellow Corporation (NASDAQ: YELL): Bankruptcy Filing Sends Shockwaves Through the Market – Unexpected Investor Surge

Analysts Bullish on LifeMD, Inc. (NASDAQ: LFMD): Median Price Target at $7.50, 97% Upside Potential

Regenerative Medicine Powerhouses Unite: Carmell Therapeutics (Nasdaq: CTCX) and Axolotl Biologix

Tupperware Brands (NYSE: TUP) vs. WallStreetBets: Decoding Investor Sentiment

BullFrog AI (NASDAQ: BFRG): Advancing Precision Medicine with AI

Steakholder Foods (NASDAQ: STKH) Partners with GCC Government for 3D-Printed Food Revolution

PSQ Holdings (NYSE: PSQH): Unraveling the Phenomenal Investor Interest Post-Listing

Cracking the Code: Understanding Sympathy Plays and their Impact on Stocks like Vroom Inc. (NASDAQ: VRM)

Mullen Automotive, Inc (NASDAQ: MULN): Investor Interest Continues to Surge, But Challenges Persist

Institutional Investors Flock to Quantum-Si (NASDAQ: QSI) as the Stock Continues to Soar

Unveiling the Phenomenon: FingerMotion Inc. (NASDAQ: FNGR) Ignites Retail Investor Army

Liminal BioSciences (NASDAQ: LMNL) Announces Acquisition Agreement with SALP for 135% Premium

Unlocking Potential: Biodexa Pharmaceutical’s (NASDAQ: BDRX) MTX110 Study Progress Triggers Trading Frenzy

Mobilicom (NASDAQ: MOB) Secures Landmark Deal with Top Global Manufacturer

Unexpected Market Moves: Vinco Ventures (NASDAQ: BBIG) Sparks Rumors and Twitter Buzz

Caribou Biosciences (NASDAQ: CRBU) Secures $25M Pfizer (NYSE: PFE) Investment, Bolstering Cancer Treatment Research

Analysis of BioXcel Therapeutics’ (NASDAQ: BTAI) Alzheimer’s Trial: Unraveling the 42% Surge

Revolutionizing Diabetes Care: Nemaura Medical (NASDAQ: NMRD) Paves the Way Through Innovative Solutions and Partnerships

VBI Vaccines (NASDAQ: VBIV) Secures Lucrative Government Contract for 2023 Adult Vaccines

Entertainment

MSP Recovery (NASDAQ: LIFW) in the Spotlight: Legal Battles, Luxe Living, and Stock Surge

Solowin Holdings (NASDAQ: SWIN) 95% Stock Rally: Analyzing the Market Hype and IPO Impact”

Advancing Medical Frontiers: Elutia Inc.’s(NASDAQ: ELUT) Strategic Vision in a $600 Million Market

FingerMotion, Inc. (NASDAQ: FNGR): A Closer Look at its 500% Surge

Navigating the Green Wave: US Cannabis ETF (NYSE: MSOS) A Closer Look at Cannabis Stock Resurgence

First Wave BioPharma’s (NASDAQ: FWBI) Exclusive License: Repurposing Capeserod for GIT Disorder Solutions

ZyVersa Therapeutics’ (NASDAQ: ZVSA) Breakthrough: A Super Tool for Tackling Inflammation in ALS and Beyond

Creative Medical Technology NASDAQ: CELZ) Major Breakthrough: Allogeneic Cell Line Paves the Way for Diabetes Treatment

Aurora Cannabis (NASDAQ: ACB) Focuses on Debt Reduction and Positive Cash Flow Amidst Flourishing Cannabis Industry

MSP Recovery (NASDAQ: LIFW) in the Spotlight: Legal Battles, Luxe Living, and Stock Surge

Solowin Holdings (NASDAQ: SWIN) 95% Stock Rally: Analyzing the Market Hype and IPO Impact”

Advancing Medical Frontiers: Elutia Inc.’s(NASDAQ: ELUT) Strategic Vision in a $600 Million Market

Meta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)

Medium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)

Healthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward

Recent Posts

Recent Comments